The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Advances in Platinum Chemotherapeutics
Abstract
The approved platinum(II)‐based anticancer agents cisplatin, carboplatin and oxaliplatin are widely utilised in the clinic, although with numerous disadvantages. With the aim of circumventing unwanted side‐effects, a great deal of research is being conducted in the areas of cancer‐specific targeting, drug administration and drug delivery. The targeting of platinum complexes to cancerous tissues can be achieved by the attachment of small molecules with biological significance. In addition, the administration of platinum complexes in the form of platinum(IV) allows for intracellular reduction to release the active form of the drug, cisplatin. Drug delivery includes such technologies as liposomes, dendrimers, polymers and nanotubes, with all showing promise for the delivery of platinum compounds. In this paper we highlight some of the recent advances in the field of platinum chemotherapeutics, with a focus on the technologies that attempt to utilise the cytotoxic nature of cisplatin, whilst improving drug targeting to reduce side‐effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
Rosi, N. L., Giljohann, D. A., Thaxton, C. S., Lytton-Jean, A. K. R., Han, M. S., & Mirkin, C. A. (2006) · Science · doi:10.1126/science.1125559 · Cited by 1,988
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Molecular aspects of ligand binding to serum albumin.
Kragh-Hansen, U. (1981) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06849-8 · Cited by 1,544
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,367
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Nano-aggregates of single-walled graphitic carbon nano-horns
Iijima, S., Yudasaka, M., Yamada, R., Bandow, S., Suenaga, K., Kokai, F., & Takahashi, K. (1999) · Chemical Physics Letters · doi:10.1016/s0009-2614(99)00642-9 · Cited by 1,194
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Amphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., & Kamen, B. A. (1992) · PubMed · Cited by 1,011
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
Bhirde, A. A., Patel, V., Gavard, J., Zhang, G., Sousa, A. A., Masedunskas, A., Leapman, R. D., Weigert, R., Gutkind, J. S., & Rusling, J. F. (2009) · ACS Nano · doi:10.1021/nn800551s · Cited by 853
Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin
Petitpas, I., Bhattacharya, A. A., Twine, S., East, M., & Curry, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100575200 · Cited by 825
Lebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754
Cisplatin and platinum drugs at the molecular level (Review)
Boulikas, T., & Vougiouka, M. (2003) · Oncology Reports · doi:10.3892/or.10.6.1663 · Cited by 729
Dhar, S., Liu, Z., Thomale, J., Dai, H., & Lippard, S. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803036e · Cited by 700
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
Feazell, R. P., Nakayama-Ratchford, N., Dai, H., & Lippard, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073231f · Cited by 616
PATRI, A., KUKOWSKALATALLO, J., & BAKERJR, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.014 · Cited by 597
Oligonucleotide Loading Determines Cellular Uptake of DNA-Modified Gold Nanoparticles
Giljohann, D. A., Seferos, D. S., Patel, P. C., Millstone, J. E., Rosi, N. L., & Mirkin, C. A. (2007) · Nano Letters · doi:10.1021/nl072471q · Cited by 552
Chemistry of polyethylene glycol conjugates with biologically active molecules
Zalipsky, S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00023-z · Cited by 552
Overexpression of folate binding protein in ovarian cancers
Toffoli, G., Cernigoi, C., Russo, A., Gallo, A., Bagnoli, M., & Boiocchi, M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970422)74:2<193::aid-ijc10>3.0.co;2-f · Cited by 521
Dhar, S., Daniel, W. L., Giljohann, D. A., Mirkin, C. A., & Lippard, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9071282 · Cited by 510
The biological chemistry of folate receptors
Antony, A. (1992) · Blood · doi:10.1182/blood.v79.11.2807.2807 · Cited by 495
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
Vitamin B12and folate in relation to the development of Alzheimer’s disease
Wang, H.-X., Wahlin, A., Basun, H., Fastbom, J., Winblad, B., & Fratiglioni, L. (2001) · Neurology · doi:10.1212/wnl.56.9.1188 · Cited by 469
Bae, Y., Jang, W.-D., Nishiyama, N., Fukushima, S., & Kataoka, K. (2005) · Molecular BioSystems · doi:10.1039/b500266d · Cited by 445
Arunachalam, B., Phan, U. T., Geuze, H. J., & Cresswell, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.745 · Cited by 438
Ligand-targeted liposomal anticancer drugs
Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 438
Polymer-drug conjugates: Recent development in clinical oncology
Li, C., & Wallace, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.009 · Cited by 436
Tumour-inhibiting platinum complexes—state of the art and future perspectives
Jakupec, M. A., Galanski, M. S., & Keppler, B. K. (2003) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/s10254-002-0001-x · Cited by 434
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Houghton, A. N., & Polsky, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00161-7 · Cited by 414
Carbon Nanohorns as Anticancer Drug Carriers
Ajima, K., Yudasaka, M., Murakami, T., Maigné, A., Shiba, K., & Iijima, S. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500566 · Cited by 411
New Cisplatin Analogues in Development: A Review
Weiss, R. B., & Christian, M. C. (1993) · Drugs · doi:10.2165/00003495-199346030-00003 · Cited by 404
Dendrimer-platinate: a novel approach to cancer chemotherapy
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00010 · Cited by 402
Huang, J. C., Zamble, D. B., Reardon, J. T., Lippard, S. J., & Sancar, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10394 · Cited by 347
Hannon, M. J. (2007) · Pure and Applied Chemistry · doi:10.1351/pac200779122243 · Cited by 313
Ultrasound triggered release of cisplatin from liposomes in murine tumors
Schroeder, A., Honen, R., Turjeman, K., Gabizon, A., Kost, J., & Barenholz, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.007 · Cited by 305
A potent cytotoxic photoactivated platinum complex
Mackay, F. S., Woods, J. A., Heringová, P., Kašpárková, J., Pizarro, A. M., Moggach, S. A., Parsons, S., Brabec, V., & Sadler, P. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707742105 · Cited by 303
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy
Gindy, M. E., & Prud'homme, R. K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902932908 · Cited by 298
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Boulikas, T. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903114168 · Cited by 276
Barnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 263
Photoactivatable Platinum Complexes
Bednarski, P. J., Mackay, F. S., & Sadler, P. J. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007779314053 · Cited by 244
Toxicity of Single-Walled Carbon Nanohorns
Miyawaki, J., Yudasaka, M., Azami, T., Kubo, Y., & Iijima, S. (2008) · ACS Nano · doi:10.1021/nn700185t · Cited by 241
Ajima, K., Murakami, T., Mizoguchi, Y., Tsuchida, K., Ichihashi, T., Iijima, S., & Yudasaka, M. (2008) · ACS Nano · doi:10.1021/nn800395t · Cited by 240
Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers.
Bharali, D. J., Khalil, M., Gurbuz, M., et al. (2009) · PubMed · Cited by 238
Liposomal, Nanoparticle, and Conjugated Formulations of Anticancer Agents
Zamboni, W. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1895 · Cited by 234
Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
Choy, H., Park, C., & Yao, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2176 · Cited by 217
Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women
Somboonporn, W., & Davis, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0016 · Cited by 214
Calabretta, M. K., Kumar, A., McDermott, A. M., & Cai, C. (2007) · Biomacromolecules · doi:10.1021/bm0701088 · Cited by 209
He, Q., Liang, C. H., & Lippard, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100108697 · Cited by 209
Nanoparticle Albumin-Bound Paclitaxel: A Novel Cremphor-EL ® -Free Formulation of Paclitaxel
Stinchcombe, T. E. (2007) · Nanomedicine · doi:10.2217/17435889.2.4.415 · Cited by 205
Top, S., El Hafa, H., Vessieres, A., Quivy, J., Vaissermann, J., Hughes, D. W., McGlinchey, M. J., Mornon, J.-P., Thoreau, E., & Jaouen, G. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00137a010 · Cited by 170
Murphy, G. P., Elgamal, A. A., Su, S. L., et al. (1998) · PubMed · Cited by 168
ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
Nowotnik, D. P., & Cvitkovic, E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.004 · Cited by 167
Length‐Dependent Uptake of DNA‐Wrapped Single‐Walled Carbon Nanotubes
Becker, M. L., Fagan, J. A., Gallant, N. D., Bauer, B. J., Bajpai, V., Hobbie, E. K., Lacerda, S. H. D. P., Migler, K. B., & Jakupciak, J. P. (2007) · Advanced Materials · doi:10.1002/adma.200602667 · Cited by 162
White, S. C., Lorigan, P. C., Margison, G. P., Margison, J. M., Martin, F., Thatcher, N., Anderson, H., & Ranson, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603345 · Cited by 152
Murphy, G. P., Elgamal, A. A., Su, S. L., Bostwick, D. G., & Holmes, E. H. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981201)83:11<2259::aid-cncr5>3.0.co;2-t · Cited by 150
Polymer Therapeutics for Cancer: Current Status and Future Challenges
Satchi‐Fainaro, R., Duncan, R., & Barnés, C. M. (2005) · Springer eBooks · doi:10.1007/12_024 · Cited by 146
Dragovich, T., Mendelson, D. S., Kurtin, S. E., Richardson, K., Hoff, D. D. V., & Hoos, A. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0235-4 · Cited by 142
Jodrell, D. I., Evans, T. R. J., Steward, W. P., Cameron, D., Prendiville, J., Aschele, C., Noberasco, C., Lind, M., Carmichael, J., Dobbs, N. A., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.04.032 · Cited by 130
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): Phase I study
Stathopoulos, G. P., Boulikas, T., Vougiouka, M., Deliconstantinos, G., Rigatos, S., Darli, E., Viliotou, V., & Stathopoulos, J. (2005) · Oncology Reports · doi:10.3892/or.13.4.589 · Cited by 128
Systemic Lipoplatin infusion results in preferential tumor uptake in human studies.
Boulikas, T., Stathopoulos, G. P., Volakakis, N., & Vougiouka, M. (2005) · PubMed · Cited by 126
Anticancer therapeutics: “Addictive” targets, multi-targeted drugs, new drug combinations
Broxterman, H. J., & Georgopapadakou, N. H. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.07.002 · Cited by 125
Mantovani, L., Miotti, S., Ménard, S., Canevari, S., Raspagliesi, F., Bottini, C., Bottero, F., & Colnaghi, M. I. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90257-7 · Cited by 120
Pratesi, G., Perego, P., Polizzi, D., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690620 · Cited by 118
Rice, J. R., Gerberich, J. L., Nowotnik, D. P., & Howell, S. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2169 · Cited by 117
Ogawara, K.-I., Un, K., Tanaka, K.-I., Higaki, K., & Kimura, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.008 · Cited by 101
Jackson, A. R., Davis, J., Pither, R. J., Rodger, A., & Hannon, M. J. (2001) · Inorganic Chemistry · doi:10.1021/ic010152a · Cited by 94
Novel and emerging approaches for the delivery of metallo-drugs
Sánchez-Cano, C., & Hannon, M. J. (2009) · Dalton Transactions · doi:10.1039/b912708a · Cited by 93
Júnior, Á. D. D. C., Mota, L. G., Nunan, E. A., Wainstein, A. J. A., Wainstein, A. P. D. L., Leal, A. S., Cardoso, V. N., & Oliveira, M. C. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.10.011 · Cited by 72
Amouri, H., Vessières, A., Vichard, D., Top, S., Gruselle, M., & Jaouen, G. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00095a006 · Cited by 72
Harris, A. L., Ryan, J. J., & Farrell, N. P. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.018762 · Cited by 58
Gagnon, V., St-Germain, M.-É., Descôteaux, C., Provencher-Mandeville, J., Parent, S., Mandal, S. K., Asselin, É., & Bérubé, G. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.015 · Cited by 55
Perron, V., Rabouin, D., Asselin, É., Parent, S., Gaudreault, R. C., & Bérubé, G. (2004) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2004.06.009 · Cited by 50
Gandolfi, O., Blum, J., & Mandelbaum-Shavit, F. (1984) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)81847-2 · Cited by 35
Estrogen Treatment Induces Elevated Expression of HMG1 in MCF-7 Cells
Chau, K., Lam, H. Y. P., & Lee, K. D. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4052 · Cited by 35
The role of pro-drug therapy in the treatment of cancer
Ferguson, M., Ahmed, F. Y., & Cassidy, J. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0207 · Cited by 31
Drug Delivery Devices and Targeting Agents for Platinum(ii) Anticancer Complexes
Krause‐Heuer, A. M., Grant, M. P., Orkey, N., & Aldrich-Wright, J. R. (2008) · Australian Journal of Chemistry · doi:10.1071/ch08157 · Cited by 16
Self-citation
Cited by
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
Large, D. E., Abdelmessih, R. G., Fink, E. A., & Auguste, D. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113851 · Cited by 877
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Wilson, J. J., & Lippard, S. J. (2014) · Chemical Reviews · doi:10.1021/cr4004314 · Cited by 630
Metadata
- Authors
- Harper, B. W., Krause‐Heuer, A. M., Grant, M. P., Manohar, M., Garbutcheon‐Singh, K. B., & Aldrich‐Wright, J. R.
- Venue
- Chemistry – A European Journal
- Publisher
- Wiley
- Published
- 2010-06-21
- Volume
- 16
- Issue
- 24
- Pages
- 7064-7077
- ISSN
- 0947-6539 (ISSN-L)
- 1521-3765
- OpenAlex
- W2166302315
- Cited by
- 267
- References
- 96
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.